Skip to content

Studies

Master's Degrees

School of Engineering

Master’s Degree in Analytical Chemistry Master’s Degree in Pharmaceutical Chemistry Master’s Degree in Chemical Engineering Master’s Degree in Industrial Engineering Master’s Degree in Bioengineering Master’s Degree in Biopharmaceutical Business Master’s Degree in Cosmetics and Fragrances Master’s Degree in Materials Science and Engineering

School of Management

Master’s Degree in International Marketing in a Digital Environment Master’s Degree in Auditing and Management Control Master’s Degree in Wealth and Financial Management Master’s Degree in Industrial Business Management Master in Global Entrepreneurial Management Master's Degree in Neuromarketing Master's Degree in Accounting, Data Analytics and ESG Reporting

School of Engineering + School of Management

Master’s Degree in Circular Economy
Programme finder
Master’s Admissions Master's Scholarships Master’s Open Days International Students

Dual Master’s Degree

School of Engineering and Management

Dual Master’s Degree in Analytical Chemistry and Industrial Business Management Dual Master’s Degree in Pharmaceutical Chemistry and Industrial Business Management Dual Master’s Degree in Bioengineering and Industrial Business Management Dual Master’s Degree in Chemical Engineering and Industrial Business Management Dual Master’s Degree in Industrial Engineering and Industrial Business Management Dual Master’s Degree in Industrial Engineering and Chemical Engineering Dual Master’s Degree in Biopharmaceutical Business and Bioengineering Dual Master’s Degree in Biopharmaceutical Business and Pharmaceutical Chemistry
Programme finder
Master’s Admissions Master's Scholarships Master’s Open Days International Students

Executive Education

Másters

Executive MBA Máster en Dirección de Operaciones Máster en Dirección de Compras Estratégicas Máster en Packaging Management Máster en Dirección de Empresas Hoteleras Máster en Organización de Eventos y Turismo de Negocios Máster en Neuromárketing

Posgrados

Posgrado en Ingenería de Plantas Farmacéuticas Posgrado Product & Process Engineering Managament Posgrado Manufacturing Plant Leadership Posgrado Global Logistics & Supply Chain Management Posgrado en Gestión Estratégica de Compras (MIP) Posgrado en Envasado, Logística y Circularidad del Packaging Posgrado Packaging Project Management Posgrado Diseño Estructural y Desarrollo de Packaging Posgrado en Perfumes y Fragancias, Mercado y Aplicaciones Posgrado Dirección Avanzada del Laboratorio de Calidad Posgrado en Tecnología de Pinturas Posgrado en Ética Medioambiental Posgrado en Hotelería de Lujo Posgrado en IA y Web3 aplicada a Alojamientos Turísticos Posgrado en Gobierno y Dirección de la Pyme (Vértice)
Soluciones In Company Enfocados y cápsulas formativas
Programme finder
Admisión Executive Education
Prospective Students International IQS Students Alumni Companies
ca en es
Home ❯ Research projects ❯ IMMUTOL (Advanced antigen-specific dendritic cell-based therapy to re-establish tolerance in immunemediated diseases)

IMMUTOL (Advanced antigen-specific dendritic cell-based therapy to re-establish tolerance in immunemediated diseases)

Funds Source:

European Union

Period:

01/05/2023 to 30/04/2027

Project status:

ACTIVE

Funding:

273,779 €

IMMUTOL is the Accelerated development and validation of an advanced therapeutic drug (ATMP) based on modified VitD3

The aim of IMMUTOL isthe fast-track development and validation of an advanced therapeutic medicinal product (ATMP) based on VitD3-modified tolerogenic DC for immunotherapy approaches.

Through a multidisciplinary approach, IMMUTOL will leverage the power of tolerogenic VitD3DC-based immunotherapy to develop a more potent and durable treatment for MS and, in turn other autoimmune inflammatory diseases with an unmet medical need. In parallel, it will bring information about tolerance mechanisms and patient-specific requirements for manufacturing effective tolDC products.
https://immutol-horizon.eu

Research groups

GEVAB – Vascular Engineering and Applied Biomedicine Group

The GEVAB group develops its activity in two main areas: the development of biomaterials to treat vascular pathologies and the study of other clinical needs, integrating knowledge from medicine, biology, chemistry, physics, mathematics and computing.